Pharma conclave series 2024: Pharma (Day1)
Virtual event: Pharma conclave series 2024
SCIEX offers the platform for the experts to take the stage and drive technological progress
Welcome to Pharma conclave series 2024 – where our customers’ expertise meets innovation, transforming your knowledge and empowering you to revolutionize your work processes. Join us in discovering techniques that will enhance your skills to accelerate your daily operations in the development of new drugs.
From the research of new markers to the drug development moving into non and GLP bioanalysis. Confidently plan your next lab expansion with the knowledge gained from industry leaders and pioneers.
- May 16 Event 1: Pharma omics
- September 17 Event 2: Impurities
- October 23-24 Event 3: Pharma
10:00 a.m.–12:00 p.m. CET
Event 3: Pharma
The pharma connection
From discovery to QA/QC. All the process to bring a new treatment to the patients is following a path to connect the different stages until the magic happens.
Join to see how the scientists are generating the needed tricks to connect the initial though with the final formulation.
Day 1
10:00 - 10:30 - Metabolomics screening kits for use in clinical trials
- Heike Wiese, Nuvisan
10:30 – 11:00 - Sphingolipid biomarkers in neurodegenerative drug development
- Jose Carlos Gonzalez, AMSbiopharma
11:00 – 11:30 - Parallel setup of a series of micro LC methods, coupled with the low-resolution mass spec (API7500) for TG2 inhibitors
- Davide Massari and Chiara Olmi, ERBC Group
11:30 – 12:00 - PFAS analysis and mass spectrometry: Beyond environmental, food and packaging. What about cosmetic and pharmaceutical products?
- Emiliano De Dominicis, Merieux
Presenter: Bruno Manadas, PhD
Dr Manadas is a prominent Cell Biology researcher at CNC-UC since 2017. With expertise in biochemistry, psychology, and biotechnology, he's authored 130+ publications and led multiple projects. As head of CNC's Mass Spectrometry node and Associate Editor for Frontiers, he's contributed significantly to neuroscience and psychiatry. Bruno's research focuses on cell biology mechanisms, translational biomarker research, and MS-based approaches for studying protein oxidation. He played a pivotal role in establishing the hospital biobank and teaches at the Portuguese Catholic University.
Presenter: Dorte Bekker-Jensen
Dorte is heading the Applications Development team in Proteomics Research at Evosep. She has long-term experience within proteomics and has focused on technology development by developing simple and automated workflows for high-throughput applications.
Presenter: Stefan Ledinger
Stefan has 20 years of experience in the life sciences and diagnostic industries. For the last dozen years, he has been serving various functions within biocrates life sciences ag. Most recently, he has been responsible for the market development for metabolomics solutions in the pharmaceutical and biotech industries. He currently serves as Global Head of Sales. Stefan holds degrees in business administration and bioengineering, combining commercial know-how with a passion for science.
Presenter: Markus Langsdorf
Markus has 14 years of experience in life sciences industries. As he joined biocrates in 2010, he worked for 11 years as application support specialist for biocrates’ metabolomics profiling solutions. 3 years ago he changed his position withing the company to his new function as product manager. Markus studied chemistry and graduated with a PhD in Analytical Chemistry.
